| http://dbpedia.org/ontology/abstract
|
La milacemida (INN) es un inhibidor de la … La milacemida (INN) es un inhibidor de la MAO-B y prodroga de glicina. Se ha estudiado por sus efectos sobre la memoria humana y como tratamiento potencial para los síntomas de la enfermedad de Alzheimer. Los ensayos clínicos iniciales, sin embargo, no mostraron resultados positivos.bargo, no mostraron resultados positivos.
, Milacemide (INN) is an MAO-B inhibitor and … Milacemide (INN) is an MAO-B inhibitor and glycine prodrug. It has been studied for its effects on human memory and as a potential treatment for the symptoms of Alzheimer's disease. Early clinical trials did not show positive results however, and the drug is now abandoned and it is sold as a nonprescription drug or supplement. While milacemide is not an amino-acid, it acts similarly to glycine in the brain.it acts similarly to glycine in the brain.
|
| http://dbpedia.org/ontology/iupacName
|
2-(Pentylamino)acetamide
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Milacemide.svg?width=300 +
|
| http://dbpedia.org/ontology/wikiPageID
|
33357837
|
| http://dbpedia.org/ontology/wikiPageLength
|
3534
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1026888047
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/MAO-B +
, http://dbpedia.org/resource/Prodrug +
, http://dbpedia.org/resource/Alzheimer%27s_disease +
, http://dbpedia.org/resource/Category:NMDA_receptor_agonists +
, http://dbpedia.org/resource/International_Nonproprietary_Name +
, http://dbpedia.org/resource/Tricine +
, http://dbpedia.org/resource/Category:Monoamine_oxidase_inhibitors +
, http://dbpedia.org/resource/Amino_acid +
, http://dbpedia.org/resource/Category:Amino_acid_derivatives +
, http://dbpedia.org/resource/Category:Glycine_receptor_agonists +
, http://dbpedia.org/resource/Glycine +
, http://dbpedia.org/resource/Category:Abandoned_drugs +
, http://dbpedia.org/resource/Category:Prodrugs +
|
| http://dbpedia.org/property/imagefile
|
Milacemide.svg
|
| http://dbpedia.org/property/imagename
|
Skeletal formula of milacemide
|
| http://dbpedia.org/property/pin
|
2
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Cascite +
, http://dbpedia.org/resource/Template:Chemspidercite +
, http://dbpedia.org/resource/Template:Chembox_Identifiers +
, http://dbpedia.org/resource/Template:Chembox_Properties +
, http://dbpedia.org/resource/Template:Chembox +
, http://dbpedia.org/resource/Template:Stdinchicite +
, http://dbpedia.org/resource/Template:Ebicite +
, http://dbpedia.org/resource/Template:Nervous-system-drug-stub +
, http://dbpedia.org/resource/Template:Fdacite +
, http://dbpedia.org/resource/Template:Chemboximage +
, http://dbpedia.org/resource/Template:Chembox_Related +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Monoamine_metabolism_modulators +
, http://dbpedia.org/resource/Template:Ionotropic_glutamate_receptor_modulators +
, http://dbpedia.org/resource/Template:Glycine_receptor_modulators +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Prodrugs +
, http://dbpedia.org/resource/Category:Monoamine_oxidase_inhibitors +
, http://dbpedia.org/resource/Category:Abandoned_drugs +
, http://dbpedia.org/resource/Category:NMDA_receptor_agonists +
, http://dbpedia.org/resource/Category:Glycine_receptor_agonists +
, http://dbpedia.org/resource/Category:Amino_acid_derivatives +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Inhibitor +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Milacemide?oldid=1026888047&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Milacemide.svg +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Milacemide +
|
| owl:sameAs |
http://yago-knowledge.org/resource/Milacemide +
, http://sr.dbpedia.org/resource/Milacemid +
, http://www.wikidata.org/entity/Q5676259 +
, http://es.dbpedia.org/resource/Milacemida +
, http://sh.dbpedia.org/resource/Milacemid +
, http://rdf.freebase.com/ns/m.0h7pghp +
, https://global.dbpedia.org/id/4keaL +
, http://dbpedia.org/resource/Milacemide +
|
| rdf:type |
http://dbpedia.org/ontology/ChemicalCompound +
, http://dbpedia.org/class/yago/Communication100033020 +
, http://dbpedia.org/class/yago/HigherCognitiveProcess105770664 +
, http://dbpedia.org/class/yago/ProblemSolving105796750 +
, http://dbpedia.org/class/yago/Thinking105770926 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://dbpedia.org/class/yago/Message106598915 +
, http://dbpedia.org/ontology/Drug +
, http://dbpedia.org/class/yago/Calculation105802185 +
, http://dbpedia.org/class/yago/Statement106722453 +
, http://www.wikidata.org/entity/Q11173 +
, http://dbpedia.org/class/yago/DerivedFunction106014730 +
, http://dbpedia.org/class/yago/WikicatMolecularFormulas +
, http://dbpedia.org/class/yago/MolecularFormula106817173 +
, http://dbpedia.org/class/yago/Formula106816935 +
, http://dbpedia.org/class/yago/Process105701363 +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/class/yago/PsychologicalFeature100023100 +
, http://dbpedia.org/class/yago/Cognition100023271 +
, http://dbpedia.org/class/yago/WikicatAminoAcidDerivatives +
|
| rdfs:comment |
Milacemide (INN) is an MAO-B inhibitor and … Milacemide (INN) is an MAO-B inhibitor and glycine prodrug. It has been studied for its effects on human memory and as a potential treatment for the symptoms of Alzheimer's disease. Early clinical trials did not show positive results however, and the drug is now abandoned and it is sold as a nonprescription drug or supplement. While milacemide is not an amino-acid, it acts similarly to glycine in the brain.it acts similarly to glycine in the brain.
, La milacemida (INN) es un inhibidor de la … La milacemida (INN) es un inhibidor de la MAO-B y prodroga de glicina. Se ha estudiado por sus efectos sobre la memoria humana y como tratamiento potencial para los síntomas de la enfermedad de Alzheimer. Los ensayos clínicos iniciales, sin embargo, no mostraron resultados positivos.bargo, no mostraron resultados positivos.
|
| rdfs:label |
Milacemide
, Milacemida
|
